As institution with both a Primate Center and a Clinical and Translational Science Award (CTSA), we’ve been closely following the proposed dissolution of the National Center for Research Resources (NCRR) and creation of a new center, the National Center for Advancing Translational Sciences (NCATS).
Last week, the NIH released a statement called, “Separating Fact & Fiction: News about the Proposed National Center for Advancing Translational Sciences.” The statement addresses an article in the New York Times published on January 22 that describes NCATS as the “government’s new drug center.” This unusual statement attempts to reassure stakeholders that the New York Times and other media outlets may have mischaracterized the nature of the changes. It notes that “NCATS is not intended to be a drug company” and that “[t]here are no plans to ‘cannibalize’ the budgets or programs of other NIH Institutes and Centers to form NCATS.”
Until a plan is finalized, visit the NIH Feedback website to learn more or to submit your own comments. You can also view a recording of Daniel Dorsa, PhD, vice president for research at OHSU, presenting on Critical NIH Changes.